Merck (MRK) CEO Davis receives 47,434 shares from 94% PSU payout
Rhea-AI Filing Summary
Merck & Co., Inc. Chairman, CEO & President Robert M. Davis reported an acquisition of common stock tied to a performance award. On January 26, 2026, he received 47,434 shares of common stock at a stated price of $107.4 per share, coded as an acquisition. The footnote explains this was a distribution of net after‑tax shares following satisfaction of performance criteria for performance share units granted on March 31, 2023, with performance shares paid out at 94% of target awards, including accrued dividends over a three‑year performance period ending December 31, 2025. After this distribution, Davis directly beneficially owns 491,035.757 common shares.
Positive
- None.
Negative
- None.
Insights
CEO received 47,434 Merck shares from performance-based award vesting.
The transaction shows Robert M. Davis, Merck’s Chairman, CEO & President, acquiring 47,434 common shares on January 26, 2026. It is labeled as an acquisition and tied to previously granted performance share units, not an open-market purchase.
The footnote states the award relates to performance share units granted on March 31, 2023, paid at 94% of target, and includes dividends accrued over a three-year period ending December 31, 2025. This links the share delivery directly to multi-year performance conditions.
After this distribution, Davis directly holds 491,035.757 Merck common shares. This filing documents how earlier performance-based incentives translated into actual share ownership, with the scale and timing defined by the award’s original terms and performance outcomes.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 47,434 | $107.40 | $5.09M |
Footnotes (1)
- [object Object]